Hidradenitis suppurativa and associated factors: Still unsolved problems

Journal of the American Academy of Dermatology

Volumn 61, Issue 2, 2009, Pages 362-365

  Matusiak, Łukasz ^a   Bieniek, Andrzej ^a   Szepietowski, Jacek Cezary ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; TESTOSTERONE;

ADOLESCENT; ADULT; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; HYPERANDROGENISM; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; ONSET AGE; POLAND; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SUPPURATIVE HIDRADENITIS; SWEATING;

ADULT; AGE DISTRIBUTION; COMORBIDITY; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; INCIDENCE; MALE; OBESITY; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; YOUNG ADULT;

EID: 67650158773     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.03.043     Document Type: Letter

References (18)

1. Revuz J.E., Canoui-Poitrine F., Wolkenstein P., Viallette C., Gabison G., Pouget F., et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59 (2008) 596-601
2. Weyandt G. Surgical management of acne inversa. [inGerman]. Hautarzt 56 (2005) 1033-1039
3. Mortimer P.S., Dawber R.P., Gales M.A., and Moore R.A. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed) 292 (1986) 245-248
4. König A., Lehmann C., Rompel R., and Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 198 (1999) 261-264
5. Radhakrishna U., Blouin J.L., Mehenni H., Mehta T.Y., Sheth F.J., Sheth J.J., et al. Genetic analysis of three large Indian pedigrees with autosomal dominant hidradenitis suppurativa. Exp Dermatol 15 (2006) 479
6. McLean H.I., Wood P., Irvine A.D., and von der Werth J. Mapping of two genetic loci for autosomal dominant hidradenitis suppurativa. Exp Dermatol 15 (2006) 479
7. Gao M., Wang P.G., Cui Y., Yang S., Zhang Y.H., Lin D., et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol 126 (2006) 1302-1306
8. Hurley H. Dermatologic surgery, principles and practice (1989), Marcel Dekker, New York
9. In: Dmochowska H. (Ed). Statistical yearbook of the Republic of Poland 2007 (2007), Zakład Wydawnictw Statystycznych, Warszawa
10. Mandal A., and Watson J. Experience with different treatment modules in hidradenitis suppurativa: a study of 106 cases. Surgeon 3 (2005) 23-26
11. Kurzen H., Hana A., Frongia G., Goerdt S., and Gratchev A. The potential role of acetylocholine receptors in acne inversa (HS) pathogenesis. Exp Dermatol 15 (2006) 480
12. Hana A., Booken D., Henrich C., Gratchev A., Maas-Szabowski N., Goerdt S., et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 80 (2007) 2214-2220
13. Sellheyer K., and Krahl D. "Hidradenitis suppurative" is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol 44 (2005) 535-540
14. Głogowski C, Gierczyński J, Niewada M. Koszty cukrzycy typu 2 na świecie i w PolsceMenedżer Zdrowia 2004;4.
15. Fitzsimmons J.S., Guilbert P.R., and Fitzsimmons E.M. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 113 (1985) 1-8
16. Joseph M.A., Jayaseelan E., Ganapathi B., and Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 16 (2005) 75-78
17. Mortimer P.S., Dawber R.P., Gales M.A., and Moore R.A. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115 (1986) 263-268
18. Lewis F., Messenger A.G., and Wales J.K.H. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol 129 (1993) 447-448